Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other ... Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Mehr anzeigen
Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing PR Newswire LOS ANGELES, Dec. 19, 2024 Aadi Enters into Exclusive...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -1.6501650165 | 3.03 | 3.27 | 2.91 | 218444 | 3.11657884 | CS |
| 4 | 0.18 | 6.42857142857 | 2.8 | 3.812 | 2.7519 | 335345 | 3.28845701 | CS |
| 12 | 0.965 | 47.8908188586 | 2.015 | 3.812 | 1.94 | 363929 | 3.07866378 | CS |
| 26 | 1.51 | 102.721088435 | 1.47 | 3.812 | 1.21 | 279025 | 2.48696797 | CS |
| 52 | 1.31 | 78.4431137725 | 1.67 | 3.812 | 1.21 | 283091 | 2.19598465 | CS |
| 156 | -16.67 | -84.834605598 | 19.65 | 21.15 | 1.21 | 200092 | 5.53962674 | CS |
| 260 | -27.02 | -90.0666666667 | 30 | 32.99 | 1.21 | 193795 | 7.2599619 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
